南印度结核分枝杆菌全基因组测序提示新耐药机制与区域特异性诊断需求
该研究对印度南部泰米尔纳德邦Tiruvallur和Madurai地区196例患者中随机选取的223株结核分枝杆菌进行全基因组测序,比较基因组学分析显示谱系1和3流行、同一治疗中心内近期传播、耐药随时间在患者内出现、已知耐药突变对印度菌株表型耐药解释不足,并提示可能存在未报道的耐药突变或多菌株感染干扰基因型耐药预测。结论强调当前技术对耐药结核快速诊断和感染控制的挑战。
要点
- 印度南部结核菌以谱系1和3为主,存在同一治疗中心内近期传播。
- 已知耐药突变不能充分解释印度菌株的表型耐药,可能存在新耐药机制。
- 多菌株感染可干扰基于基因型的耐药预测,需区域特异性诊断策略。
核心结论
- 南印度结核分枝杆菌全基因组分析揭示谱系1和3的遗传多样性及耐药进化特点,提示当前基于已知突变的基因型耐药预测在印度菌株中可能不足。
研究设计与样本
- 对印度南部Tiruvallur和Madurai地区196例患者中随机选取的223株结核分枝杆菌进行全基因组测序,并开展比较基因组学分析。
主要发现
- 基因组分析显示谱系1和3菌株流行,同一治疗中心患者间存在近期传播,耐药可在患者内随时间出现。
- 耐药获得顺序与不同谱系和地理来源菌株的典型模式一致。
- 已知耐药相关突变对印度菌株表型耐药的解释力相对其他地区研究不足,耐药可能源于既往未涉及的突变或多菌株感染。
临床怎么用
- 在印度等高负担地区,应警惕现有基因型耐药预测工具的局限性,结合表型药敏和区域特异性诊断方法。
- 同一治疗中心内近期传播提示需加强感染控制措施。
局限性
- 原文未明确报告样本量之外的具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND.: India is home to 25% of all tuberculosis cases and the second highest number of multidrug resistant cases worldwide. However, little is known about the genetic diversity and resistance determinants of Indian Mycobacterium tuberculosis, particularly for the primary lineages found in India, lineages 1 and 3. METHODS.: We whole genome sequenced 223 randomly selected M. tuberculosis strains from 196 patients within the Tiruvallur and Madurai districts of Tamil Nadu in Southern India. Using comparative genomics, we examined genetic diversity, transmission patterns, and evolution of resistance. RESULTS.: Genomic analyses revealed (11) prevalence of strains from lineages 1 and 3, (11) recent transmission of strains among patients from the same treatment centers, (11) emergence of drug resistance within patients over time, (11) resistance gained in an order typical of strains from different lineages and geographies, (11) underperformance of known resistance-conferring mutations to explain phenotypic resistance in Indian strains relative to studies focused on other geographies, and (11) the possibility that resistance arose through mutations not previously implicated in resistance, or through infections with multiple strains that confound genotype-based prediction of resistance. CONCLUSIONS.: In addition to substantially expanding the genomic perspectives of lineages 1 and 3, sequencing and analysis of M. tuberculosis whole genomes from Southern India highlight challenges of infection control and rapid diagnosis of resistant tuberculosis using current technologies. Further studies are needed to fully explore the complement of diversity and resistance determinants within endemic M. tuberculosis populations.
引用
- Manson AL, Abeel T, Galagan JE, et al. Mycobacterium tuberculosis Whole Genome Sequences From Southern India Suggest Novel Resistance Mechanisms and the Need for Region-Specific Diagnostics. Clin Infect Dis. 2017. PMID: 28498943. doi:10.1093/cid/cix169
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。